A group of Chilean investors has acquired Farmacias Ahumada
A group of Chilean investors has acquired Farmacias Ahumada S.A. from Walgreens Boots Alliance.
The acquisition is carried out by a selected group of non-institutional chilean investors.
Founded in 1968, Farmacias Ahumada operates as one of the three main pharmaceutical chains in Chile, with almost 300 drugstores. It offers a range of products and services, such as drugs, natural products, nutritional supplements and beauty items and personal care products. The company is based in Santiago.
Walgreens Boots Alliance is an American public multinational holding headquartered in Illinois. It is an integrated healthcare, pharmacy and retail leader, which owns the pharmacy chains Walgreens in the US and Boots in the UK and internationally, as well as the Benavides brand in Mexico.
Oaklins’ team in Chile advised a group of Chilean investors on the acquisition of Farmacias Ahumada.
Contáctese con el equipo de la transacción
Transacciones relacionadas
Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
Conozca másPiper PE and Cool Japan Fund have backed a management buy-out of Inside Travel Group
Inside Travel Group (ITG) has been sold to Piper PE and Cool Japan Fund. This acquisition aligns with ITG’s goal of becoming the leading specialist in tailor-made and group tours across Asia. Piper PE and Cool Japan Fund will continue to support ITG’s founders and management team, driving the business’ growth in Japan and other Asian destinations.
Conozca másCreo Medical Group plc has completed a US$15.7 million equity fundraise
Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.
Conozca más